This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
7 Mar 2011

Bayer Extends Support to Fight Chagas Disease

Bayer HealthCare signed an extension of its collaboration agreement with WHO to fight a deadly tropical disease.

Bayer HealthCare has extended its agreement with the World Health Organization to fight Chagas disease, a deadly and neglected tropical disease (NTD). The five-year extension will come into effect in April 2012, when the previous agreement signed in 2007 had been set to expire.

 

Bayer HealthCare underlines its commitment to its successful collaboration with WHO and ensures that ongoing projects and initiatives can continue beyond the initial timeline. Bayer HealthCare has also committed to doubling its initial donation of 2.5 million Lampit? tablets (active ingredient: nifurtimox) for the treatment of Chagas disease to a total of 5 million by 2017. In addition, the company will contribute 1.5 million US dollars in cash to fund logistics and distribution.

Related News